<DOC>
	<DOCNO>NCT00002506</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention therapy use certain drug try prevent development recurrence cancer . The use isotretinoin may effective way prevent cancer stop cancer grow . Interferon alfa may interfere growth cancer cell . Combining isotretinoin interferon may effective treatment recurrent cancer . PURPOSE : Phase II trial study effectiveness interferon alfa plus isotretinoin treating patient recurrent cancer .</brief_summary>
	<brief_title>Isotretinoin Plus Interferon Treating Patients With Recurrent Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate treatment daily subcutaneous interferon alpha plus oral isotretinoin patient advance squamous cell carcinoma follow body site : head neck , cervix , skin , esophagus , lung , penis . II . Determine toxicity side effect treatment . OUTLINE : Nonrandomized study . Single-agent Chemotherapy Biological Response Modifier Therapy . Isotretinoin , 13-CRA , NSC-329481 ; Interferon alpha ( Schering Hoffmann-La Roche ) , IFN-A , NSC-377523 NSC-367982 . PROJECTED ACCRUAL : 14-50 patient per tumor category ( tumor location , available ) enrol . If none first 14 patient tumor category responds , 1/22 , 2/30 , 3/37 , 4/44 , 5/50 respond , treatment consider ineffective tumor type .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Skin Neoplasms</mesh_term>
	<mesh_term>Penile Neoplasms</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Isotretinoin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven squamous cell carcinoma fail standard local modality local disease and/or effective systemic therapy metastatic disease , form systemic therapy refuse Eligible site include limited : Uterine cervix Head neck Skin Esophagus Lung Penis Measurable evaluable disease require Measurable disease define previously unirradiated disease reproducibly measurable 2 dimension physical exam , xray , CT , MRI , radiologic procedure Documented progressive disease previously irradiate site accept measurable Evaluable disease include : Any visible radiologic disease measurable 2 perpendicular diameter Elevated squamous cell carcinoma antigen ( SCCA ) No active brain metastasis Previously treat brain metastasis respond therapy exclude , CNS disease consider measurable evaluable PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Hematopoietic : WBC least 3,000 Platelets least 100,000 Hct least 30 % Hepatic : Bilirubin le 2.0 mg/dl PT normal PTT normal Renal : Creatinine le 2.0 mg/dl Cardiovascular : No MI within 6 month No CHF require medication No arrhythmia require medication Pulmonary : Reasonable respiratory reserve require No requirement supplemental oxygen No dyspnea rest Other : No chronic underlying immunodeficiency disease No HIV positivity No pregnant patient ( negative pregnancy test require ) Adequate birth control require fertile patient PRIOR CONCURRENT THERAPY : Biologic therapy : No concomitant immunosuppressive drug , e.g. , cyclosporin Chemotherapy : At least 3 week since prior systemic chemotherapy recovery Endocrine therapy : No concomitant corticosteroid Radiotherapy : No prior radiotherapy measurable site unless disease progression document Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>recurrent esophageal cancer</keyword>
	<keyword>recurrent cervical cancer</keyword>
	<keyword>squamous cell lung cancer</keyword>
	<keyword>squamous cell carcinoma skin</keyword>
	<keyword>recurrent penile cancer</keyword>
	<keyword>recurrent skin cancer</keyword>
	<keyword>squamous cell carcinoma esophagus</keyword>
	<keyword>cervical squamous cell carcinoma</keyword>
	<keyword>penile squamous cell carcinoma</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
</DOC>